Stability of 5 mg/mL Nitrendipine Oral Suspension in Syrspend® SF PH4

Stability of 5 mg/mL Nitrendipine Oral Suspension in Syrspend® SF PH4

Nitrendipine is prescribed to children for the treatment of primary hypertension (off-label use). Available specialties (Nidrel®, Baypress® and others generic drugs) are only marketed in tablet form, which is unsuitable for pediatric use. A hospital preparation of nitrendipine oral suspension at 5 m...

Full description

Bibliographic Details
Main Authors: Bellay Romain, Bonnaure Anne-Claire, Rault Pauline, Pertuisel Sophie, Lester Marie-Antoinette, Boivin Pierre-Nicolas
Format: Article
Language:English
Published: De Gruyter 2018-03-01
Series:Pharmaceutical Technology in Hospital Pharmacy
Subjects:
pediatrics
hypertension
calcium-channel blockers
stability
hplc
Online Access:https://doi.org/10.1515/pthp-2017-0030

Internet

https://doi.org/10.1515/pthp-2017-0030

Similar Items